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Abstract
Excess in mitochondrial reactive oxygen species (ROS) is consid-
ered as a major cause of cellular oxidative stress. NADPH, the main
intracellular reductant, has a key role in keeping glutathione in its
reduced form GSH, which scavenges ROS and thus protects the cell
from oxidative damage. Here, we report that SIRT5 desuccinylates
and deglutarylates isocitrate dehydrogenase 2 (IDH2) and glucose-
6-phosphate dehydrogenase (G6PD), respectively, and thus acti-
vates both NADPH-producing enzymes. Moreover, we show that
knockdown or knockout of SIRT5 leads to high levels of cellular
ROS. SIRT5 inactivation leads to the inhibition of IDH2 and G6PD,
thereby decreasing NADPH production, lowering GSH, impairing
the ability to scavenge ROS, and increasing cellular susceptibility
to oxidative stress. Our study uncovers a SIRT5-dependent mecha-
nism that regulates cellular NADPH homeostasis and redox poten-
tial by promoting IDH2 desuccinylation and G6PD deglutarylation.
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Introduction
Cellular damage caused by aberrant reactive oxygen species (ROS)
is considered as a major cause in many age-related diseases.
To prevent from ROS-induced damage, cells have developed a
metabolic network to maintain intracellular levels of nicotinamide
adenine dinucleotide phosphate (NADPH), a major cellular reduc-
tant, and thus a proper redox state. NADPH is commonly used to
keep glutathione in its reduced form GSH, which scavenges ROS
and converts harmful hydrogen peroxide to water with the help of
glutathione peroxidase (GSHPx) [1]. In this process, GSH is oxidized
to its disulfide, GSSG. Perturbed NADPH production disrupts cell
division, increases cell sensitivity to ROS, and provokes apoptosis
[2]. Major NADPH-producing enzymes are glucose-6-phosphate
dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase
(6PGD) in the pentose phosphate pathway (PPP), malic enzyme
(ME) in the pyruvate cycling pathway, methylenetetrahydrofolate
dehydrogenase 1 and 2 (MTHFD1/2) in the one-carbon metabolic
pathway, and isocitrate dehydrogenase 1 and 2 (IDH1/2) which
catalyzes the oxidative decarboxylation of isocitrate and produces
alpha-ketoglutarate (a-KG) outside the context of the tricarboxylic
acid cycle (TCA cycle). In addition to a critical role in maintaining
NADPH homeostasis, IDH1 and IDH2 enzymes have recently
received great attention because their mutated forms produce an
oncometabolite 2-hydroxyglutarate, which can alter the epigenetic
landscape by inhibiting multiple a-KG-dependent histone and DNA
demethylases [3].
Large-scale proteomic surveys of cellular proteins have demon-
strated that lysines can be posttranslationally modified by various
types of acylations, including acetylation [4–6], succinylation [7],
malonylation [8,9], glutarylation [10], crotonylation [11,12], propi-
onylation [13], and butyrylation [13]. Among these posttranslational
modifications, protein acetylation is the most well-studied regulatory
mechanism for multiple metabolic processes [14,15]. To date, more
than 4,500 acetylated proteins have been identified [16]. In addition,
recent studies have discovered that succinylation, malonylation, and
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glutarylation, which are structurally similar, can also regulate meta-
bolic pathways [10,17–20]. The potential presence of a transferase
for lysine succinylation, malonylation, or glutarylation has not been
identified yet, and investigation on the regulation of these three acidic
lysine modifications has mainly been focusing on the deacylase
sirtuin 5 (SIRT5) [10,21]. However, little is known about the biology
that regulated by SIRT5. Phenotypical characterization conducted in
Sirt5 knockout (KO) mice reveals that these animals exhibit appar-
ently normal size, body weight, food intake, mobility, and fertility
under normal physiological conditions [22]. Of note, when exposed
to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Sirt5 KO
mice display more severe nigrostriatal dopaminergic degeneration
and accelerated motor deficit [23]. The dopaminergic neurotoxin
MPTP blocks complex I (NADH-ubiquinone oxidoreductase) of the
mitochondrial electron transport chain, generates ROS, and subse-
quently induces neuronal death [24,25], recapitulating the hallmarks
of Parkinson’s disease in humans [26]. Moreover, Sirt5 KO mice
exhibit a higher susceptibility to ischemia–reperfusion injury in the
heart, which is associated with increased generation of ROS [27].
These findings point out that SIRT5 may preserve cellular antioxi-
dant capacity, although the underlying mechanism still remains
unclear. This study is directed toward understanding how SIRT5
regulates cellular redox status and susceptibility to oxidative
damage. Our results uncover a previously unknown mechanism by
which SIRT5 desuccinylates and deglutarylates IDH2 and G6PD,
respectively, and activates both enzymes to maintain cellular
NADPH homeostasis and redox potential during oxidative stress.
Results and Discussion
Sirt5 protects cells from oxidative damage
SIRT5 is a global regulator of lysine succinylation, malonylation,
and glutarylation in mitochondria and can impact enzymes involved
in diverse mitochondrial metabolic pathways [10,17–20]. To deci-
pher the role of SIRT5 in regulating mitochondrial function, we
investigated murine embryonic fibroblasts (MEFs) isolated from
Sirt5 wild-type (WT) and KO mice littermates. Western blot analysis
demonstrated that as expected, the protein expression of Sirt5 was
abolished in Sirt5 KO MEFs (Fig EV1A). The effect of SIRT5 defi-
ciency on overall mitochondrial function was evaluated by measur-
ing the oxygen consumption rate (OCR), an indicator of oxidative
phosphorylation, in the presence of a series of metabolic inhibitors
and uncoupling agents (Fig EV1B and C). As shown, the basal
oxygen consumption was significantly (P < 0.001) decreased by
26% in Sirt5 KO MEFs compared to WT control cells. The rate of
oligomycin-sensitive oxygen consumption, which reflects the
amount of oxygen consumption linked to ATP production [28], was
significantly (P < 0.001) decreased by 31% in Sirt5 KO MEFs
compared to WT control cells. After oligomycin, cells were treated
with FCCP, which permeabilizes the inner mitochondrial membrane
and induces maximal and uncoupled respiration [29,30]. The
response to FCCP was also significantly (P < 0.01) lower in Sirt5 KO
MEFs than WT cells. These results suggest that SIRT5 is important
for preserving normal respiratory capacity of mitochondrion.
Given that oxidative phosphorylation is one of the main sources
for ROS production in mammalian cells [31], we determined ROS
levels in Sirt5 KO and WT MEFs. Surprisingly, we found that
although oxidative phosphorylation is impaired in Sirt5 KO MEFs,
the ROS level was significantly (P < 0.01) increased by twofold in
Sirt5 KO MEFs compared to WT control cells (Fig 1A). Moreover,
the ratios of [GSH/GSSG] and [NADPH/NADP+] were reduced by
77% (P < 0.05) and 50% (P < 0.001), respectively, in Sirt5 KO
MEFs compared to WT control cells (Fig 1B and C). Furthermore,
Sirt5 KO MEFs displayed a significant (P < 0.001) reduction in cellu-
lar growth rate (Fig 1D). These MEFs also exhibited remarkably
higher levels of cleaved PARP and caspase-3, two indicators of
apoptosis, when subjected to paraquat (a toxin which impairs cellu-
lar redox cycling and induces ROS formation) (Fig 1E), and conse-
quently, a significantly (P < 0.01) higher incidence of cell death
upon paraquat treatment (Fig 1F). These results imply that SIRT5
regulates cellular redox status at least in part by modulating NADPH
homeostasis in cultured cells.
Figure 1. Sirt5 protects cells from oxidative stress.
A Sirt5 deficiency leads to higher ROS levels in MEFs. ROS levels were determined in the indicated MEFs as described in the Materials and Methods. The results are
average  SD of three independent experiments, **P < 0.01 (two-tailed unpaired t-test).
B Sirt5 deficiency suppresses GSH production in MEFs. The ratio of [GSH/GSSG] was determined in cell extracts as described in the Materials and Methods. The results
are average  SD of three independent experiments, *P < 0.05 (two-tailed unpaired t-test).
C Sirt5 deficiency inhibits NADPH production in MEFs. The ratio of [NADPH/NADP+] was determined in cell extracts as described in the Materials and Methods. The
results are average  SD of three independent experiments, ***P < 0.001 (two-tailed unpaired t-test).
D Sirt5 deficiency decreases cell growth. MEF cells were seeded in 6-well plates at a density of 50,000 cells/well, and cell growth rate was carefully monitored every
1–2 days by cell counting for 8 days. The results are average  SD of three independent experiments, *P < 0.05, ***P < 0.001 (two-tailed unpaired t-test).
E Sirt5 deficiency leads to higher sensitivity of MEFs to paraquat. The levels of cleaved PARP and caspase-3 were determined by Western blot analysis.
F Sirt5 protects MEFs from ROS-induced cell death. Wild-type and Sirt5 KO MEFs were treated with paraquat (500 lM) for 24 h, and then, cell viability was
determined by counting the remaining adherent cells. The results are average  SD of three independent experiments, **P < 0.01 (two-tailed unpaired t-test).
G–I Sirt5 deficiency inhibits the production of NADPH and GSH and increases lipid peroxide in mouse brains after paraquat injection. Female Sirt5 KO and WT
littermates (n = 3–5 per group) were intraperitoneally injected with saline or paraquat (10 mg/kg) once a week for 3 consecutive weeks. The ratios of [NADPH/
NADP+] and [GSH/GSSG] and the level of lipid peroxide were determined in tissue extracts. The results are average  SD. *P < 0.05, n.s.: not significant (two-tailed
unpaired t-test).
J, K Sirt5 KO mice are more sensitive to paraquat-induced nigrostriatal dopaminergic degeneration. Female Sirt5 KO and WT littermates were treated with paraquat as
in (G–I). The brain sections were stained to detect tyrosine hydroxylase (TH)-positive dopaminergic neurons in the SNc region, as described in the Materials and
Methods. Representative immunohistochemistry images (original magnification, 100×; scale bar, 100 lm) and the corresponding quantifications are shown in (J)
and (K), respectively. The results are average  SD. *P < 0.05, n.s.: not significant (two-tailed unpaired t-test).
Source data are available online for this figure.
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Next, we compared the in vivo response of female Sirt5 KO mice
and WT littermates after paraquat injection. As shown, no signifi-
cant difference in the [NADPH/NADP+] or [GSH/GSSG] ratio was
found in the brain of Sirt5 KO and WT mice under non-stress condi-
tion (upon saline injection). However, the [NADPH/NADP+] and
[GSH/GSSG] ratios were significantly (P < 0.05) lower in the brain
of Sirt5 KO mice than WT controls under oxidative stress condition
(upon paraquat challenge) (Fig 1G and H). In accord, the level of
lipid peroxide (MDA) was significantly (P < 0.05) higher in the
brain of Sirt5 KO mice than WT controls after paraquat injection
(Fig 1I). Moreover, Sirt5 KO mice appear to be more sensitive to
paraquat-induced nigrostriatal dopaminergic degeneration, as the
number of tyrosine hydroxylase (TH)-positive dopaminergic
neurons was significantly (P < 0.05) reduced in the substantia nigra
pars compacta (SNc) region in the brain of Sirt5 KO mice after para-
quat injection (Fig 1J and K). These findings support a crucial role
of SIRT5 in regulating NADPH homeostasis and the redox status
in vivo.
SIRT5 preserves cellular antioxidant capacity partially through
activating NADPH-producing G6PD and IDH2
To check whether SIRT5 could regulate cellular redox status in other
cell types besides MEFs, we generated stable HEK293T cells with
SIRT5 knockdown by retrovirus infection (Fig EV2A). SIRT5 knock-
down significantly (P < 0.01) reduced the [NADPH/NADP+] ratio
by as much as 36%, reaffirming that SIRT5 is an important contribu-
tor to NADPH pools in the cell (Fig 2A). The lower [NADPH/
NADP+] ratio is in line with the lower [GSH/GSSG] ratio and higher
ROS in SIRT5 knockdown cells (Fig 2B and C). Moreover, SIRT5
knockdown cells exhibited higher levels of cleaved PARP and
caspase-3 as well as a higher incidence of cell death when subjected
to paraquat (Fig 2D and E). Notably, the sensitivity to paraquat-
induced cell death positively correlated with the SIRT5 knockdown
efficiency, as shRNA #2 was more potent in both SIRT5 knockdown
and changing the redox parameters (i.e., [GSH/GSSG] ratio,
[NADPH/NADP+] ratio, and ROS) than shRNA #1. Collectively,
these findings further support an important role of SIRT5 in control-
ling NADPH homeostasis and protecting cells from oxidative
damage.
To determine which NADPH-producing enzyme(s) may contri-
bute to the observed redox imbalance in SIRT5 knockdown cells, we
measured the activity of NADPH-producing enzymes, including
G6PD, 6PGD, ME1, MTHFD1/2, and IDH1/2 in SIRT5 knockdown
HEK293T cells (Fig 2F). Our data demonstrated that the activities of
endogenous G6PD/6PGD and IDH1/2, but not ME1 and MTHFD1/2,
were substantially reduced in SIRT5 knockdown cells and that the
reduction in enzyme activity of G6PD/6PGD or IDH1/2 was posi-
tively correlated with the SIRT5 knockdown efficiency in these cells
(Fig 2G). SIRT5 knockdown reduced activities of endogenous G6PD
and IDH2 without changing their protein levels in HEK293T cells
(Fig EV2B), indicating that the inhibitory effect of SIRT5 depletion
on G6PD and IDH2 is most likely to be posttranslational. To test
whether SIRT5 directly regulate the activity of NADPH-producing
enzymes, we next expressed Flag-tagged protein of G6PD, 6PGD,
ME1, MTHFD1, MTHFD2, IDH1, or IDH2 in HEK293T cells,
immunoprecipitated with Flag beads, eluted by Flag peptides, and
then incubated each protein with His-tagged SIRT5 in vitro. Interest-
ingly, our data demonstrated that the activities of G6PD and IDH2,
but not the other enzymes, were significantly increased when co-
incubated with SIRT5 (Fig 2H). Taken together, these results
suggest that SIRT5 modulates cellular NADPH homeostasis and
protects cells from oxidative stress at least in part by maintaining
the activity of G6PD and IDH2.
SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation
to activate these two enzymes and maintain NADPH homeostasis
Previous proteomic studies have identified a large number of
succinylated, malonylated, and glutarylated proteins [10,17–20].
Among these identified acylated proteins are several NADPH-producing
metabolic enzymes, including human G6PD and IDH2 as well as
mouse Idh2 (Fig EV3). It has previously been reported that
succinyl-CoA can lead to nonenzymatic succinylation of lysine resi-
dues in proteins [32]. As expected, when immunoprecipitated Flag-
tagged G6PD or IDH2 was incubated with succinyl-CoA in vitro,
lysine succinylation of each protein was dramatically increased
(Fig 3A and B). Succinyl-CoA incubation significantly (P < 0.05)
decreased the activity of Flag-IDH2, while the activity of Flag-G6PD
was largely unaffected (Fig 3A and B), suggesting that succinylation
Figure 2. SIRT5 preserves cellular antioxidant capacity partially through activating NADPH-producing G6PD and IDH2.
A Knockdown of SIRT5 inhibits NADPH production in HEK293T cells. The ratio of [NADPH/NADP+] was determined in cell extracts as described in the Materials and
Methods. The results are average  SD of three independent experiments, **P < 0.01, ***P < 0.001 (two-tailed unpaired t-test).
B Knockdown of SIRT5 suppresses GSH production in HEK293T cells. The ratio of [GSH/GSSG] was determined in cell extracts as described in the Materials and Methods.
The results are average  SD of three independent experiments, **P < 0.01 (two-tailed unpaired t-test).
C Knockdown of SIRT5 leads to higher ROS levels in HEK293T cells. ROS levels were determined in the indicated stable cells as described in the Materials and Methods.
The results are average  SD of three independent experiments, ***P < 0.001 (two-tailed unpaired t-test).
D Knockdown of SIRT5 leads to higher sensitivity to paraquat. The expression levels of PARP and caspase-3 were determined by Western blot analysis.
E SIRT5 protects HEK293T cells from ROS-induced cell death. The indicated stable HEK293T cells were treated as mentioned in (D), and then, cell viability was
determined by counting the remaining adherent cells. The results are average  SD of three independent experiments, **P < 0.01 (two-tailed unpaired t-test).
F Cartoon representation of major NADPH-producing enzymes in the cell. As shown, G6PD, 6PGD, ME1, IDH1, and MTHFD1 are located in the cytosol, while IDH2 and
MTHFD2 are located in mitochondria.
G The activities of G6PD/6PGD and IDH1/2 are reduced in stable HEK293T cells with SIRT5 knockdown. Activities of the indicated endogenous proteins were determined
in cell extracts as described in the Materials and Methods. The results are average  SD of three independent experiments, *P < 0.05, **P < 0.01, ***P < 0.001, n.s.:
not significant (two-tailed unpaired t-test).
H G6PD and IDH2 are activated by SIRT5 in vitro. Upon pre-incubation with SIRT5 in vitro, the activities of the indicated ectopically expressed proteins were determined
as described in the Materials and Methods. The results are average  SD of three independent experiments, **P < 0.01, n.s.: not significant (two-tailed unpaired t-test).
Source data are available online for this figure.
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may negatively regulate IDH2, but not G6PD. Supporting this
notion, the succinylation level of Flag-IDH2 was increased, while
IDH2 enzyme activity was significantly (P < 0.001) decreased by
41% in SIRT5 knockdown HEK293T cells (Fig 3C). On the other
hand, co-overexpression of Flag-IDH2 with HA-SIRT5 decreased
IDH2 succinylation, but significantly increased IDH2 enzyme activ-
ity (P < 0.01, increased by ~1.6-fold) (Fig 3D). Moreover, depletion
of endogenous SIRT5 or co-overexpression of HA-SIRT5 did not
affect lysine glutarylation, malonylation, and acetylation of Flag-
IDH2 (Fig 3C and D). These findings suggest that SIRT5 regulates
IDH2 activity by controlling IDH2 succinylation.
There are 17 different lysine residues in IDH2 which can poten-
tially be modified by succinylation [17,18,20]. Among these, several
sites seem to be highly targeted by SIRT5, including K80, K155,
K263, K360, and K413. Based on the crystal structure [33], two
lysine sites, K360 and K413, which are adjacent to the substrate
binding site, imply that succinylation of these two residues might
compromise the binding pocket for isocitrate and inhibit IDH2 activ-
ity (Fig 3E). To test this hypothesis, we mutated each of these two
putative succinylation sites to arginine (R). The K to R mutation
retains a positive charge and is often used as a desuccinylated
mimetic. We found that, like wild-type IDH2, the activity of K360R
mutant IDH2 was decreased by SIRT5 knockdown and was
increased by SIRT5 overexpression (Fig 3F and G). Interestingly,
K413R mutant IDH2 displayed a negligible response to either SIRT5
knockdown or SIRT5 overexpression in changing enzyme activity
(Fig 3F and G), suggesting that K413 in IDH2 may be a key succiny-
lation site that is directly targeted by SIRT5.
Moreover, our data demonstrated that the glutarylation level of
Flag-G6PD was increased in HEK293T cells with SIRT5 knock-
down, which may contribute to a significant reduction in G6PD
enzyme activity (P < 0.01, decreased by 48%) (Fig 3C). On the
other hand, co-overexpression of Flag-G6PD with HA-SIRT5 led to
a reduction in G6PD glutarylation and a concomitant increase in
G6PD enzyme activity (P < 0.05, increased by ~1.6-fold) (Fig 3D).
Lysine succinylation, malonylation, and acetylation levels of Flag-
G6PD were largely unaffected by either SIRT5 knockdown or SIRT5
co-overexpression (Fig 3C and D). Collectively, these findings
suggest that SIRT5 regulates G6PD activity by controlling G6PD
glutarylation.
SIRT5 desuccinylase activity is triggered by oxidative stimuli
Finally, we investigated whether oxidative stress alters SIRT5
expression or enzymatic activity. Western blotting and quantitative
RT–PCR showed that paraquat or H2O2 treatment had no effect on
the mRNA or protein expression of SIRT5 (Fig 4A and B). Further-
more, we observed that paraquat or H2O2 dose-dependently acti-
vated the desuccinylase activity of SIRT5 (Fig 4C and D). In vitro
incubation of purified SIRT5 protein with either paraquat or H2O2
did not affect the desuccinylase activity of SIRT5 (Fig 4C and E),
suggesting that the increased SIRT5 activity is not due to a direct
oxidation of SIRT5 by the oxidants. However, treatment of the Flag-
SIRT5 expressing HEK293T cells with paraquat or H2O2 did increase
the ability of SIRT5 to activate IDH2 (Fig 4F). Together, our data
indicate that oxidative stress can increase the desuccinylase activity
of cellular SIRT5.
Aging is a universal phenomenon observed in all organisms,
which is characterized by a progressive decline in organ functions.
The free radical theory of aging states that the process of aging is at
least partly due to the accumulation of oxidative damage caused by
ROS [34]. Indeed, numerous studies have provided evidence to
support it. For instance, C. elegans mutations that have enhanced
oxidative defense extend lifespan, whereas shorter lifespan muta-
tions are more sensitive to free radicals [35,36]. Interesting, over-
expression of catalase targeted to mitochondria leads to extension of
life span in mice, while catalase targeted to nucleus and peroxisome
have little effect [37]. One explanation is that catalase catalyzes the
decomposition of hydrogen peroxide to water and oxygen, and mito-
chondria are thought to be the major cellular source of ROS. To
prevent from ROS-induced damage, cells have developed antioxi-
dant defense systems to balance the antioxidant defenses and ROS
production during aging [38]. The redox balance is maintained in
part by ratios of some redox couples, such as the [GSH/GSSG] and
[NADPH/NADP+] ratios. NADPH is commonly required for the
generation of GSH [39], which scavenges ROS and plays a critical
◀ Figure 3. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to activate these two enzymes and maintain NADPH homeostasis.A G6PD activity is not regulated by lysine succinylation. Purified Flag-tagged G6PD was incubated with or without succinyl-CoA (1 mM) at 30°C for 15 min, followed
by measurement of G6PD enzyme activity as described in the Materials and Methods. The results are average  SD of three independent experiments. n.s.: not
significant (two-tailed unpaired t-test).
B IDH2 activity is suppressed by lysine succinylation. Purified Flag-tagged IDH2 was incubated with or without succinyl-CoA (1 mM) at 30°C for 15 min, followed by
measurement of IDH2 enzyme activity as described in the Materials and Methods. The results are average  SD of three independent experiments, *P < 0.05 (two-
tailed unpaired t-test).
C SIRT5 knockdown increases G6PD glutarylation and IDH2 succinylation, respectively, and decreases both enzyme activities. Flag-G6PD or Flag-IDH2 was ectopically
expressed in the indicated stable HEK293T cells. G6PD/IDH2 proteins were purified by immunoprecipitated with Flag beads and eluted with Flag peptide, followed
by determination of their lysine modifications and enzyme activity. The results are average  SD of three independent experiments, **P < 0.01, ***P < 0.001 (two-
tailed unpaired t-test).
D SIRT5 decreases G6PD glutarylation and IDH2 succinylation and increases both enzyme activities. Flag-G6PD or Flag-IDH2 was co-overexpressed with HA-SIRT5 in
HEK293T cells. G6PD and IDH2 proteins were purified by immunoprecipitation with Flag beads and eluted with Flag peptide, followed by determination of their
lysine modifications and enzyme activity. The results are average  SD of three independent experiments, *P < 0.05, **P < 0.01 (two-tailed unpaired t-test).
E Cartoon representation of porcine mitochondrial IDH2 structure shows isocitrate binding pocket (PDB ID: 1LWD) [33], made by Pymol (www.pymol.org). The protein
is colored in light green and isocitrate in rainbow, with Lys360 and Lys413 residues in IDH2 being colored in red.
F, G K413 in IDH2 may be a key succinylation site that is directly targeted by SIRT5. The indicated Flag-tagged IDH2 proteins were overexpressed in HEK293T cells with
stable SIRT5 knockdown or SIRT5 co-overexpression. Wild-type and mutant IDH2 proteins were purified by Flag beads and eluted with Flag peptide, followed by
measurement of IDH2 enzyme activity. The results are average  SD of three independent experiments, *P < 0.05, n.s.: not significant (two-tailed unpaired t-test).
Source data are available online for this figure.
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role in oxidative stress resistance. In addition, NADPH is also used
mostly as a reducing agent in anabolic pathways, such as lipid
synthesis, cholesterol synthesis, and fatty acid chain elongation.
Hence, maintaining cellular NADPH homeostasis is important for a
wide range of cellular processes.
Emerging evidence suggests that SIRT5 is a candidate longevity
gene as well as a risk factor for mitochondrial dysfunction-related
disease, such as Parkinson’s disease [40]. Moreover, SIRT5 defi-
ciency decreases the expression of manganese superoxide dismutase
(SOD2), a mitochondria-specific antioxidant enzyme, and exacer-
bates nigrostriatal dopaminergic degeneration caused by MPTP in
mice [23]. These findings imply a potential role of SIRT5 in cellular
protection from oxidative stress. In this study, we found that Sirt5
KO MEFs display higher ROS level and revealed a possible mecha-
nism involving posttranslational inactivation of IDH2 and G6PD. It
is known that endogenous ROS can be produced by multiple
sources, including the respiratory chain and oxidative phosphoryla-
tion in the mitochondrion, the NADPH oxidase in the plasma
membrane, and the endoplasmic reticulum and peroxisomes.
Apparently, the observed higher ROS in Sirt5-defective MEFs is not
derived from mitochondrial respiration and the OXPHOS pathway,
as the oxygen consumption rates were lower in Sirt5 KO MEFs than
WT cells. In addition to ROS production, ROS scavenging is also
crucial to balance the redox state in the cell. It is acknowledged that
cellular detoxification of, or protection against, harmful ROS
commonly requires NADPH-dependent reducing equivalents (e.g.,
GSH). We show in the current study that SIRT5 preserves cellular
antioxidant capacity partially by modulating the activity of NADPH-
producing enzymes, IDH2 and G6PD. Our study provides both
biochemical and cellular evidence demonstrating K413 in IDH2 may
be a key succinylation site that is directly targeted by SIRT5. Never-
theless, our data cannot exclude the possibility that K413R mutation
may alter IDH2 conformation in a way that the mutant enzyme
cannot be regulated by succinylation and thus is insensitive to
SIRT5. To date, no glutarylated lysine site(s) in G6PD has been
identified by proteomic studies. Therefore, the mechanism for
SIRT5 regulating G6PD glutarylation and activity still needs further
investigation. Of interest, our data show that paraquat or H2O2
dose-dependently activates the desuccinylase activity of SIRT5, with
no effect on the mRNA or protein levels of SIRT5. Future explo-
ration will be needed to illuminate how these chemical oxidants
increase SIRT5 enzyme activity.
In summary, our findings provide direct evidence showing that
SIRT5 plays an important role in mediating oxidative stress to
desuccinylate and deglutarylate IDH2 and G6PD, respectively,
thereby activating both metabolic enzymes and maintaining cellular
NADPH homeostasis and redox balance to protect against oxidative
damage.
Materials and Methods
Antibodies
Antibodies specific to SIRT5 (Cell Signaling Technology, #8782),
PARP (Cell Signaling Technology, #9532), caspase-3 (Cell Signaling
Technology, #9665), pan-succinyl-lysine (PTM-401), pan-malonyl-
lysine (PTM-901), pan-glutaryl-lysine (PTM-1151), pan-acetyl-lysine
(Cell Signaling Technology, # 9441), HA (Santa Cruz, sc-7392), and
Flag (Shanghai Genomics, 4110-20) were purchased commercially.
Plasmids
The cDNA encoding full-length human SIRT5, G6PD, 6PGD, ME1,
IDH1, IDH2, MTHFD1, and MTHFD2 were cloned into Flag- or HA-
tagged vectors (pcDNA-Flag; pcDNA-HA). Point (Site) mutations of
IDH2 were generated by QuikChange Site-Directed Mutagenesis kit
(Stratagene).
Cell culture, transfection, and treatment
Both HEK293T cells and mouse embryonic fibroblasts (MEFs) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco)
supplemented with 10% fetal bovine serum (Gibco) and antibiotics
◀ Figure 4. SIRT5 desuccinylase activity, but not its expression, is regulated by oxidative stimuli.A, B SIRT5 expression is not affected by chemical oxidant treatment. HEK293T cells were treated with paraquat (A) or H2O2 (B) for the indicated periods. The mRNA and
protein expressions of endogenous SIRT5 were determined by quantitative real-time PCR and Western blot analysis, respectively. The results are average  SD of
three independent experiments. n.s.: not significant (two-tailed unpaired t-test).
C Schematic representation of the experimental workflow for (D) and (E).
D The desuccinylase activity of SIRT5 is stimulated by oxidative stimuli. Flag-SIRT5 was ectopically expressed in HEK293T cells. The transfected cells were treated with
increasing concentrations of paraquat or H2O2 for the indicated periods. Flag-SIRT5 was purified by immunoprecipitation with Flag beads, eluted with Flag peptide,
and then subjected to the desuccinylase activity assay as described in the Materials and Methods. The SIRT5 desuccinylase activity was normalized against its
protein level. The results are average  SD of three independent experiments, *P < 0.05, ***P < 0.001 (two-tailed unpaired t-test).
E In vitro incubation with chemical oxidants does not affect the desuccinylase activity of SIRT5. Flag-tagged SIRT5 was ectopically expressed in HEK293T cells and
then purified by immunoprecipitation with Flag beads and eluted with Flag peptide. The purified Flag-SIRT5 was treated with increasing concentrations of
paraquat or H2O2 at room temperature for 1 h and then subjected to the desuccinylase activity assay as described in the Materials and Methods. The SIRT5
desuccinylase activity was normalized against its protein level. The results are average  SD of three independent experiments. n.s.: not significant (two-tailed
unpaired t-test).
F Chemical oxidants enhance the ability of SIRT5 to activate IDH2. Flag-SIRT5 was ectopically expressed in HEK293T cells, and the transfected cells were treated with
increasing concentrations of paraquat or H2O2 for the indicated periods. Flag-SIRT5 was purified by immunoprecipitation with Flag beads, eluted with Flag peptide,
and then incubated with purified Flag-IDH2 in vitro. IDH2 enzyme activity was measured as described in the Materials and Methods, normalized by its protein
level. The results are average  SD of three independent experiments, **P < 0.01, ***P < 0.001 (two-tailed unpaired t-test).
G A proposed model for a role of SIRT5 in mediating oxidative stress to increase IDH2 and G6PD activities, NADPH production, and cellular protection. SIRT5 is
activated by oxidative stress by a yet unknown mechanism. The active SIRT5 stimulates IDH2 and G6PD by desuccinylation and deglutarylation, respectively,
thereby increasing NADPH production and protecting cells from ROS damage.
Source data are available online for this figure.
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(100 units/ml penicillin and 100 lg/ml streptomycin), in 5% CO2
atmosphere at 37°C.
Plasmid transfection was carried out using the polyethyleneimine
(PEI, Sigma-Aldrich) or lipofectamine 2000 (Invitrogen).
Oxidative agents, H2O2 (Sinopharm) and paraquat (Sigma-
Aldrich), were used to induce oxidative stress.
Immunoprecipitation and Western blotting
For Flag immunoprecipitations, cells were lysed in an ice-cold
NP-40 buffer [50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 0.1%
NP-40, and protease inhibitors]. Cell lysate was incubated with anti-
Flag M2 affinity resin (Sigma-Aldrich, A2220) for 3 h at 4°C, washed
three times with ice-cold NP-40 buffer, and analyzed by SDS–PAGE
and immunoblotting. Western blot analysis was carried out accord-
ing to standard methods.
Measurement of intracellular ROS
Intracellular ROS production was determined by using a fluorescent
dye 20, 70-dichlorofluorescein diacetate (H2DCF-DA, Sigma-Aldrich).
Briefly, cells were washed with PBS and incubated with 10 lM
H2DCF-DA at 37°C for 30 min to load the fluorescent dye. Cells were
washed twice with PBS and trypsinized for menadione treatments.
Fluorescence (Ex.488 nm, Em.525 nm) was monitored by a Spectra-
Max M5 Microplate Reader (Molecular Devices).
Measurement of intracellular GSSG and GSH
Intracellular GSSG and GSH levels were determined by using liquid
chromatography–mass spectrometry (LC-MS/MS). In short, cells
were harvested in 80% (v/v) pre-cold (80°C) methanol and centri-
fuged at 4°C at 15,000 g for 15 min. The supernatants were then
subjected to LC-MS analysis using a ShimazuLC (LC-20AB pump)
system coupled with 4000 QTrap triple quadrupole mass spectro-
meter (AB sciex). A Phenomenex NH2 column (50 mm × 2.0 mm
I.D., 5-lm particle size, 100 A˚) was used. The mass spectrometer
was optimized and set up in selected reaction monitoring (SRM)
scan mode for monitoring the [M-H] of GSSG (m/z 611.6/306.2) and
GSH (m/z 306.2/142.8). The Analyst Software was used for analysis.
Measurement of intracellular NADPH and NADP+
The intracellular levels of NADPH and NADP+ were measured by
enzymatic cycling methods as previously described [41,42]. In brief,
1.5 × 106 cells were seeded in a 10-cm dish, and cells were lysed in
400 ll of extraction buffer (20 mM NAM, 20 mM NaHCO3, 100 mM
Na2CO3) and centrifuged at 1,200 × g for 15 min after 24 h. For
NADPH extraction, 150 ll of the supernatant was incubated for
30 min at 60°C; 160 ll of NADP-cycling buffer (100 mM Tris–HCl,
pH 8.0; 0.5 mM thiazolyl blue; 2 mM phenazine ethosulfate; 5 mM
EDTA) containing 1.3 U of G6PD was added to a 96-well plate
containing 20 ll of the cell extract. After incubation for 1 min at
30°C in darkness, 20 ll of 10 mM G6P was added to the mixture,
and the change in absorbance at 570 nm was measured every
30 sec for 10 min at 30°C in a SpectraMax M5 Microplate Reader
(Molecular Devices). All the samples were run in triplicate. The
concentration of NADP+ was calculated by subtracting NADPH
(heated sample) from the total of NADP+ and NADPH (unheated
sample).
Cell survival assay
Murine embryonic fibroblasts were seeded in 6-well plates at a
density of 50,000 cells/well, and cell numbers were counted every
1–2 days over a 8-day period by using Countstar IC1000. Moreover,
stable HEK293T cells were seeded in 6-well plates at a density of
4 × 104 cells/well. After incubation with 500 lM paraquat (Sigma-
Aldrich) for 24 h, the remaining living cells were trypsinized and
counted by Countstar IC1000.
Animal experiments
Sirt5 KO mice (129-strain background) were purchased from the
Jackson Laboratory. These animals were backcrossed for four gener-
ations onto the C57BL/6J background. Animals were given un-
restricted access to a standard diet and tap water. Animal experiments
were performed at Fudan Animal Center in accordance with the
animal welfare guidelines.
Paraquat injection and brain tissue preparation
Female Sirt5 KO mice and WT littermates (~12 weeks of age) were
intraperitoneally injected with paraquat (10 mg/kg, Sigma-Aldrich)
once a week for 3 consecutive weeks. Meanwhile, an equivalent
volume of saline was injected into the control groups. At 3 weeks
after injection, the animals were anesthetized with chloral hydrate
(500 mg/kg) and perfused with 0.1 M PBS (pH 7.4), fixed by 4%
paraformaldehyde (Sigma-Aldrich) in 0.1 M PBS (pH 7.4). Mouse
brains were removed from the skull immediately after perfusion,
post-fixed overnight in 4% paraformaldehyde at 4°C, and dehy-
drated with 20% and 30% sucrose dissolved in PBS. Thereafter,
frozen sections were cut at 30 lm in coronal planes by using a
freezing microtome (Leica Microsystems, Wetzlar, Germany) and
were then collected in 0.1 M PBS (pH 7.4) for further analysis.
Immunohistochemistry (IHC) analysis
Stored free-floating sections were washed in PBS for 15 min for
three times and treated for 30 min in 3% H2O2 to quench endo-
genous peroxidase activity. After washing, the sections were blocked
in 5% normal goat serum (Vector Laboratories) and 0.3% Triton
X-100 in PBS for 1 h at room temperature. The sections were then
incubated overnight at 4°C with a tyrosine hydroxylase antibody
(Merck Millipore, AB152) followed by a biotinylated goat anti-rabbit
IgG antibody (Vector Laboratories), and ABC solution (Vector Labo-
ratories). After washing in PBS, the sections were visualized using
DAB, washed in PBS, mounted on gelatin-coated slides, and air-
dried overnight. Finally, sections were dehydrated in alcohol,
cleared in xylene, and permanently mounted.
NADPH-producing enzyme activity assay
Flag-tagged enzymes were overexpressed in HEK293T cells,
immunoprecipitated, and eluted by 250 mg/ml Flag peptide (Gilson
Biochemical). Reactions were started by adding enzymes into the
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assay buffer: G6PD and 6PGD activity assay buffer: 50 mM Tris–HCl
(pH 7.6), 0.1 mM NADP+, 0.2 mM glucose-6-phosphate (G6P), or
0.2 mM 6-phosphogluconate; ME1 activity assay buffer: 50 mM
Tris–HCl (pH 7.6), 1 mM MgCl2, 0.5 mM NADP
+, and 40 mM
malate; IDH1/2 activity assay buffer: 100 mM potassium phosphate,
5 mM MgCl2, 0.25 mM NADP
+, and 2.5 mM isocitrate; and
MTHFD1/2 activity assay buffer: 2 mM potassium phosphate,
36 mM 2-mercaptoethanol, 25 mM 3-morpholinopropanesulfonate,
250 mM NADPH, and 200 lM formyl H4folate. The change in
NADPH fluorescence (Ex. 350 nm, Em.470 nm) was monitored by a
fluorescence spectrophotometer (HITACHI F-4600).
In vitro enzyme assay
Flag-tagged NADPH-producing enzymes were immunoprecipitated
with anti-Flag M2 affinity resin (Sigma-Aldrich) and eluted with Flag
peptide. The eluted proteins were incubated with His-SIRT5 (Sigma-
Aldrich) in 25 mM Tris–HCl (pH 7.5), 1 mM MgCl2, 1 mM DTT,
10% glycerol, and 1 mM NAD+ for 1 h at 37°C and then subjected
to the enzymatic activity assay and Western blot analysis.
RNA isolation and quantitative real-time PCR
Total RNA was isolated by TRIzol reagent according to the manufac-
turer instructions (Invitrogen). RNA was reverse-transcribed with
oligo-dT primers and preceded to real-time PCR with gene-specific
primers in the presence of SYBR Premix Ex Taq (TaKaRa). b-actin
was used as endogenous controls. Primers sequences (50–30):
b-actin-forward: GCACAGAGCCTCGCCTT;
b-actin-reverse: GTTGTCGACGACGAGCG;
SIRT5-forward: GCACAGAGCCTCGCCTT;
SIRT5-reverse: GTTGTCGACGACGAGCG.
SIRT5 desuccinylase activity assay
SIRT5 desuccinylase activity was determined by using a commer-
cially available SIRT5 activity assay kit (Enzo Life, BML-AK513-
0001). Briefly, immunoprecipitated samples were incubated with
Fluor de Lys-succinyl, NAD+, and the assay buffer at 37C for
60 min. Once incubation was completed, developer and nicotin-
amide were added and incubated at room temperature for 10 min.
Fluorescence (Ex.450 nm, Em.350 nm) was monitored by a Spectra-
Max M5 Microplate Reader (Molecular Devices).
Statistics
Statistical analyses were performed with a two-tailed unpaired
Student’s t-test. All data shown represent the results obtained from
triplicated independent experiments with standard errors of the
mean (mean  SD). The values of P < 0.05 were considered statisti-
cally significant.
Expanded View for this article is available online.
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